Press Releases

Greenphire Appoints Product Management Expert Derek Bluestone as New Chief Product Officer

Greenphire, a leading innovator in software solutions for improving clinical research site performance and participant satisfaction, announced the addition of product strategy expert Derek Bluestone as its new CPO.

Oxford Nanopore and Wasatch BioLabs Announce Collaboration to Transform DNA Methylation Analysis with New dWMS Product

The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.

Gifthealth Announces Strategic Partnership with United Digestive

Partnership expands Gifthealth’s presence to cover 25% of gastroenterologists nationally.

Kindeva Drug Delivery Appoints New CIO to Lead Digital Transformation Business Initiatives

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

MMS has announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance.

Octalsoft Honored with Times Gujarat Icon 2024 Award for Excellence in Technology and Innovation

Octalsoft, a global leader in clinical trial and healthcare technology solutions, is proud to announce its recognition as a Times Gujarat Icon 2024 Award winner, acknowledging the company’s exceptional contributions to the technology and healthcare sectors.

MaxisIT Introduces DTect AI under its Portfolio of AI Agents to Transform Clinical Data Review and Quality Management

MaxisIT has launched DTect AI, a new AI-driven solution within its eXchange Data Management Workbench, designed to improve data quality in clinical trials. DTect AI uses advanced models for real-time anomaly detection, data quality scoring, and intelligent recommendations, integrating seamlessly with sources like EDCs and LABs. By leveraging machine learning and natural language processing, it adapts to data patterns to ensure accuracy and accelerate data management. This solution sets a new industry standard for clinical data integrity and speeds up the drug development process, helping bring treatments to patients more efficiently.

The MAP Group acquires leading German market access consultancy, SKC

The MAP Group acquires German market access consultancy as it continues to expand internationally.

Coronado Research Limited announce appointment of Professor Jennifer Visser-Rogers as Chief Scientific Officer

Coronado Research announced today that Professor Jennifer Visser-Rogers has been appointed as Chief Scientific Officer.

Takara Bio Europe Expands Existing Gothenburg Site to Offer Custom Enzyme Manufacturing

Takara Bio Europe has announced the expansion of its Gothenburg facility, with the addition of a custom manufacturing lab. This new facility now offers a comprehensive array of customised molecular biology products, including PCR and qPCR enzymes, servicing the molecular biology needs of academic researchers, diagnostic labs, and biotech companies across EMEA, producing up to 600,000 reactions per week. With these expanded capabilities, customers can expect faster deliveries, personalised service, and real-time access to technical expertise, ensuring projects move forward efficiently while supporting sustainability goals through reduced carbon emissions.

CluePoints Appoints Richard Young as Chief Strategy Officer

RBQM innovator CluePoints has today announced that Richard Young has been appointed as its new Chief Strategy Officer. With 30 years of experience in clinical data management, Richard is an expert in his field.

CluePoints Wins Growth Award at BVA Private Equity Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has been recognized for its impressive growth at the BVA Private Equity Awards.

Biopharma PEG Provides Advanced PEG Solutions for Drug Development

Biopharma PEG has launched a range of polyethylene glycol (PEG) products for PEGylation, improving drug efficacy. With over 40 approved PEGylated drugs, interest in monodispersed PEGs is growing, as seen with Movantik. Biopharma PEG is dedicated to supporting PEGylated drug development.

Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation

ProPharma Appoints Brian Tuttle as Chief Financial Officer

Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth

CovarsaDx Welcomes Rich Masino as Senior Director of Strategic Partnerships and Business Development

CovarsaDx, a clinical research organization at the forefront of in vitro diagnostics (IVD) and medical device trials, has appointed Rich Masino as senior director of strategic partnerships and business development. Bringing over 30 years of experience in biotech, pharma, and medical device diagnostics, Masino will focus on driving growth and forging strategic partnerships across CovarsaDx and ZoaDx, while reporting directly to the company’s chief executive officer (CEO).

Biotech Capital on the Rise and Outsourcing to Accelerate in 2025 - but Uneven Growth for CDMOs

PHARMASEAL AND LEDGER RUN FORGE PARTNERSHIP TO ENHANCE CLINICAL BUSINESS OPERATIONS

PHARMASEAL specializes in state-of-the-art trial management software for life sciences (unified CTMS/eTMF) and LEDGER RUN, INC., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting, contracts and payments, announced their partnership today. Through the partnership, PHARMASEAL’S Engility® Platform software Engility CTMS, Engility eTMF and LEDGER RUN'S unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.

Inizio Medical Appoints Matt Wadyka as President, US Medical Affairs

Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials

Partnership combines revolutionary digital pathology and endoscopy solutions, enhancing drug development for IBD and other GI disorders ▪ Strategic Partnership: Streamlined, single-vendor solution, promises to improve diagnostic accuracy, boost efficiency, and enable reliable turnaround times in gastrointestinal (GI) clinical trials. ▪ Advanced GI Solutions: Enhances trial efficiency with AI-powered solutions, including reading for ulcerative colitis (UC) from Clario and histopathology services from PathAI. ▪ Integrated Workflow: Combines endoscopic and histopathology endpoints with simplified processes for CROs, sponsors, and investigational sites.